UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF ILLINOIS
July 19, 2010
IN RE YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND RELEVANT PRODUCTS LIABILITY LITIGATION
THIS DOCUMENT RELATES TO: JANA SMITH, PLAINTIFF
BAYER HEALTHCARE PHARMACEUTICALS ET AL DEFENDANTS
The opinion of the court was delivered by: Judge David R. Herndon
MDL No. 2100
This matter is before the Court on Plaintiff's motion for leave to file her first amended complaint pursuant to Federal Rule of Civil Procedure 15(c) (Doc. 9) for the purpose of adding Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc., the entities that purportedly produced and distributed Ocella (generic Yasmin). Defendants have not responded to Plaintiff's motion for leave to amend.
Upon consideration of Plaintiff's motion, the Court finds as follows:
Plaintiff's Motion to file First Amended Complaint (Doc. 9) is GRANTED. Further, the Court DIRECTS Plaintiff to file the amended complaint instanter.
David R. Herndon Chief Judge United States District Court
© 1992-2010 VersusLaw Inc.